LifeStance Therapists & Psychiatrists Athens
745 South Milledge Avenue, Suite 1A, Athens
4.3(217 Google reviews)
United States
5 listed treatment centers serving Athens-Clarke County and the surrounding area.
745 South Milledge Avenue, Suite 1A, Athens
4.3(217 Google reviews)
105 Westpark Drive, B, Athens
4.7(162 Google reviews)
745 South Milledge Avenue, Suite 1A, Athens
4.8(20 Google reviews)
740 Prince Avenue, Building 14, Athens
For people in Athens-Clarke County, the cost of SPRAVATO® depends on insurance benefits, the treatment setting, and the prescribed schedule. Both the medication and the visit for supervised administration and monitoring may be billed. Ask for an estimate that includes all expected charges, not just the nasal spray.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials, including which medicines you tried, how long you took them, and your response. Ask the treatment center which records it needs and who will submit the authorization request. An initial authorization may also require renewal during treatment.
Medicare coverage may fall under Part B or Part D depending on the plan and setting. Georgia Medicaid coverage also depends on the applicable plan and its requirements. Coverage and a center’s willingness to accept your insurance are separate questions; a directory listing does not establish either.
Manufacturer savings programs exist for eligible commercially insured patients, but they are not for people using government insurance, such as Medicare or Medicaid. Ask about current eligibility rules and which charges a program may help with rather than assuming the entire visit is included.
Before starting Spravato, ask the center and insurer:
SPRAVATO® treatment requires in-person visits to a healthcare setting certified through the SPRAVATO® REMS program. You administer the nasal spray yourself under direct observation by a healthcare provider; it is never taken home. The directory lists five entries for Athens-Clarke County, identified as Athens. Their REMS certification status is not verified in the supplied listings, so confirm certification and appointment availability directly before making plans.
For treatment-resistant depression, the typical labeled schedule starts with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber determines the schedule based on your needs; this is not a promise of a fixed timetable.
Monitoring lasts at least two hours after each dose, so allow additional time for check-in, preparation, and discharge decisions. Ask about appointment hours before arranging time off work, childcare, or other responsibilities. Early treatment can require repeated blocks of time away from your usual routine.
Arrange for someone else to drive you home after every visit. You must not drive or operate machinery until the next day after a restful sleep. Ask the center about its pickup requirements, confirm your ride in advance, and have a backup plan.
If you cannot find an available, confirmed certified center through the Athens-Clarke County listings, expand your search to listed Georgia cities such as Atlanta, Johns Creek, Alpharetta, Smyrna, Roswell, or Marietta. These listings do not establish certification or practical travel distance. Confirm services, insurance acceptance, and a workable transportation plan before scheduling.
The directory has five local entries identified as Athens, but their REMS certification status is not verified in the supplied listings. Contact a center and ask whether the location providing Spravato is currently REMS-certified and accepting new patients. Also confirm its evaluation process, appointment availability, and insurance participation. A directory entry alone does not confirm certification or that the center can provide your care.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal thoughts or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your symptoms, treatment history, and health risks to determine whether it is appropriate for you.
Coverage depends on your plan, the treatment setting, and authorization requirements. Insurers commonly request documentation of earlier antidepressant trials. Ask both the center and insurer about coverage for the medication and the supervised monitoring visit, network status, and your share of costs. Medicare and Georgia Medicaid may cover treatment depending on the plan and setting, but neither coverage nor a particular center’s acceptance should be assumed.
You self-administer the nasal spray under a healthcare provider’s direct observation in a REMS-certified setting. After each dose, staff monitor you for at least two hours for effects such as sedation, dissociation, breathing problems, and blood pressure increases. Your visit may take longer than the monitoring period. Arrange a driver home, and do not drive or operate machinery until the next day after a restful sleep.
Discuss sedation, dissociation—a sense of disconnection from yourself or your surroundings—respiratory depression, and increased blood pressure. Spravato also carries boxed warnings about abuse and misuse and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Tell the clinician about your medical history, medications, and substance use so they can assess risks and explain how monitoring supports your safety.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when needed. Do not wait for a treatment appointment if you need urgent help. In Athens-Clarke County or elsewhere in the United States, call or text 988 for crisis support. If you are in immediate danger or have a medical emergency, call 911.
Approved uses, nearby treatment centers, and medically sourced patient guides.